固本化湿方通过调控YAP治疗特应性皮炎的作用研究
本研究分析固本化湿方(AESS)成分,并在AD小鼠模型和细胞模型中探究其疗效与机制。AESS可减轻小鼠皮损、调节Th1/Th2/Th17/Treg平衡,并影响角质形成细胞YAP表达及NF-κB通路,提示其可能通过调控YAP治疗AD。
要点
- AESS可减轻AD小鼠皮损并调节Th1/Th2/Th17/Treg平衡
- AESS抑制HaCaT细胞凋亡及与THP-1细胞的黏附
- AESS疗效与角质形成细胞YAP表达变化及NF-κB通路相关
核心结论
- AESS可能通过影响YAP表达发挥治疗AD的作用,有望作为可长期使用、副作用较少的替代药物。
研究设计与样本
- 采用UPLC分析AESS主要成分,UPLC-MS分析大鼠血清中AESS化合物组成。
- 用2,4-二硝基氟苯刺激Balb/C小鼠构建AD模型,检测AESS给药后皮损及Th1/Th2/Th17/Treg平衡变化。
- 在IFN-γ/TNF-α刺激的AD样炎症细胞模型中检测AESS血清对HaCaT增殖、凋亡及与THP-1黏附的影响。
- 探究YAP表达对疗效及相关信号通路的影响。
主要发现
- UPLC确认10种成分:5种有机酸、3种黄酮、2种色酮;三批样品(S1-3)相似度均高于0.98。
- 上述10种化合物在大鼠血清中也被检测到,提示以原型成分吸收入血。
- AESS有效减轻AD小鼠皮损,调节Th1/Th2/Th17/Treg失衡,改善AD样细胞模型增殖能力,抑制HaCaT凋亡及与THP-1黏附。
- AESS降低小鼠脾脏Th17和Treg细胞中YAP表达,增加皮肤中YAP表达。
- 角质形成细胞中YAP表达改变削弱AESS疗效,AESS通过NF-κB信号通路发挥作用。
临床怎么用
- AESS可能作为AD长期替代治疗选项,但需进一步临床验证。
- 其疗效可能与调控YAP表达及NF-κB通路相关,可作为机制研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Atopic dermatitis (AD) is a chronic and recurrent skin disease. At present, there is a lack of sufficiently effective and safe medicines that can be used for a prolonged time and reduce the recurrence of AD. The Gu-Ben-Hua-Shi (AESS) formula has been used for many years with a good clinical effect on AD but its specific treatment mechanism is unknown. Methods: The main components of AESS were analyzed using ultra-high performance liquid chromatography (UPLC). The composition of AESS compounds in the serum from rats was analyzed using ultra-high performance liquid chromatography-mass spectrometry. An AD mouse model was constructed using 2,4-dinitrofluorobenzene stimulation in Balb/C mice and the effect on the reduction of skin lesions and Th1/Th2/Th17/Treg balance after AESS administration were measured. The effects of AESS serum on the proliferation and apoptosis of keratinocyte cell line HaCaT and adhesion of HaCaT to human monocyte cell line THP-1 were detected in an IFN-γ/TNF-α stimulated AD-like inflammatory cell model. The effects of Yes-associated protein (YAP) expression on the therapeutic effect and a related signaling pathway were also investigated. Results: In total, 10 components were confirmed using UPLC, namely five organic acids, three flavonoids, and two chromogenic ketones. Additionally, the similarity of the three batches of samples (S1-3) was above 0.98, indicating that the formula samples have good uniformity. These 10 compounds were also detected in rat serum, suggesting that they are absorbed into rat blood as prototype components. Furthermore, AESS effectively reduced the skin lesions in the AD mouse model, regulated the Th1/Th2/Th17/Treg imbalance, improved the proliferation ability of the AD-like cell model, and inhibited HaCaT apoptosis and adhesion to THP-1 cells. It also reduced the expression of YAP in Th17 and Treg cells of the mouse spleen and increased YAP expression in the skin. The change in YAP expression in keratinocytes weakened the curative effect of AESS, and AESS exerted its effects through the NF-κB signaling pathway. Conclusion: AESS may play a role in the treatment of AD by affecting the expression of YAP. These findings can be used to promote its use as an alternative medication for prolonged use with fewer side effects.
引用
- Jia J, Feng L, Ye S, et al. Therapeutic effect of chinese herbal medicine gu-ben-hua-shi (AESS) formula on atopic dermatitis through regulation of yes-associated protein. Front Pharmacol. 2022. PMID: 36313294. doi:10.3389/fphar.2022.929580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。